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1. Introduction 
Eosinophilic lung disease shows diverse pathological characteristics and chest imaging 
findings. It can be caused by various factors, including parasitic and fungal infections, 
allergies, drugs, radiation, hazardous materials, smoking, vasculitis, or be idiopathic. 
Among potential causes, allergic bronchopulmonary mycosis and allergic granulomatous 
vasculitis/Churg-Strauss syndrome are also associated with bronchial asthma. In 2001, 
chronic eosinophilic bronchiolitis was proposed as an atypical eosinophilic lung disease 
(Takayanagi et al., 2001). Subsequently, similar cases have been accompanied by asthma-like 
symptoms and dyspnea, suggesting an association with bronchial asthma (Nakagome et al., 
2003; Nagata et al., 2004; Tsuburai et al., 2006; Morimoto et al., 2006). We describe a case of 
bronchial asthma that showed diffuse centrilobular granular shadows and airway 
thickening on computed tomography (CT) of the chest and was diagnosed as eosinophilic 
bronchitis/bronchiolitis on histopathological examination.  
2. Case report of eosinophilic bronchiolitis in asthma 
The patient was a 56-year-old woman. Her main symptoms were dyspnea, wheezing, and a 
productive cough. The patient had a history of acute appendicitis at 20 years of age and 
sinusitis at 52 years. The family history was not relevant to the present disorder. As for 
lifestyle, the patient did not smoke or drink alcohol. She kept two dogs as pets outside of her 
home and was employed as an office worker.  
Bronchial asthma was diagnosed 8 years previously and the patient had been treated by a local 
physician. She had been hospitalized 4 times for asthma attacks. Since November 2005, the 
patient received inhaled corticosteroids, a long-acting inhaled β2-agonist, leukotriene 
modifiers, and theophylline in accordance with guidelines for the treatment of asthma. 
Because the patient had frequent exacerbations, she was referred to our hospital in July 2006.  
The physical findings on admission were as follows: height, 155.1 cm; body weight, 57.0 kg; 
body mass index, 23.7; body temperature, 36.8C; blood pressure, 120/80 mmHg; pulse rate, 
80 beats/min; respiratory rate, 24 times/min; and SaO2, 94%. The patient’s consciousness 
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was clear. Grade III wheezing was present in both lung fields, with no cardiac murmur. The 
abdomen was flat and soft, with no tenderness. There was no edema in the extremities. The 
neurological findings were normal.  
The results of blood tests were as follows: white cell count, 8.2 x 109/L (neutrophils, 40.9%; 
eosinophils, 35.4%, lymphocytes, 19.3%; and monocytes, 4.0%); hemoglobin, 13.7 g/dL; 
hematocrit, 41.1%; platelets, 329 x 109/L; serum total protein, 7.4 g/dL; serum aspartate 
aminotransferase, 16 U/L; serum alanine aminotransferase, 10 U/dL; serum lactate 
dehydrogenase, 190 U/L; C-reactive protein, 0.44 mg/dL; antinuclear antibody titer, 1:80; 
myeloperoxidase antineutrophil cytoplasmic antibody titer, <10 EU; proteinase 3-
antineutrophil cytoplasmic antibody titer, <10 EU; and IgE, 411 IU/mL. Anti-SS-A/B 
antibody, aspergillus antibody, aspergillus-precipitating antibody, and human T-cell 
leukemia virus type-1 antibody were all negative. Radioallergosorbent testing showed that 
specific IgE antibodies to house dust, Dermatophagoides pternysinus, aspergillus, candida, 
alternaria, cedar, ragweed, wormwood, orchard grass, cat dander, dog dander, and moth 
were negative. Blood gas values while the patient was breathing room air were as follows: 
pH, 7.43; PaCO2, 31.8 Torr; and PaO2, 69.8 Torr. Sputum cultures showed normal flora.  
The results of lung function tests were as follows: VC, 1.84 L (74.1%); FEV1, 0.72 L (35.1%); 
FEV1%(G), 47.4%; and %DLCO, 77.1%. On airway hyperreactivity testing (acetylcholine 
inhalation test), the PC20 was 2800 g/mL. The exhaled nitric oxide concentration (eNO) 
was 184.4 ppb. The CXR and the HRCT findings on admission are shown in Figure 1. On 
bronchoscopy the numbers of cells in the bronchoalveolar lavage (BAL) fluid were as 
follows: total cell count, 12.6 x 105/mL; monocytes, 22.9%; neutrophils, 0.4%; lymphocytes, 
7.4%; and eosinophils, 68.7%. Histopathological findings of transbronchial lung biopsy 
(TBLB) specimens and transbronchial biopsy (TBB) specimens are shown in Figure 2.  
3. Course after admission 
The patient had symptoms of bronchial asthma such as dyspnea, wheezing, and hypoxemia 
on admission. Chest imaging studies showed bronchial and bronchiolar lesions. Since the 
patient had peripheral-blood eosinophilia, a diagnosis of eosinophilic bronchiolitis, recently 
proposed as a distinct clinical entity, was suspected.  
Bronchoscopy was performed on the 6th day. There was an increased total cell count in  
the BAL fluid, and the proportion of eosinophils had risen by 68.7%. TBLB and TBB 
suggested bronchitis/bronchiolitis with eosinophilic infiltration. There was no evidence of 
allergy to aspergillus or other fungi and no peripheral neuritis or vasculitis. Allergic 
bronchopulmonary mycosis and allergic granulomatous vasculitis were thus unlikely. Since 
airway hyperreactivity was confirmed on an acetylcholine inhalation test, bronchial asthma 
associated with eosinophilic bronchiolitis was diagnosed.  
The patient received fluticasone (400 µg/d) since the date of admission, and prednisolone 
(40 mg/d) was started immediately after bronchoscopy. After starting treatment, symptoms 
improved dramatically. Dyspnea and wheezing decreased in several days and oxygen 
inhalation was stopped after 5 days of prednisolone treatment. The peripheral eosinophil 
count decreased from 2902 x 106/L to 47 x 106/L after 7 days of treatment. There was also 
improvement in the shadows on the chest images, as well as lung function. The eNO  
level decreased from 184.4 to 42.9 ppb. The dose of prednisolone was tapered, and 
hydrofluoroalkane(HFA)-beclomethasone (200 µg/d) was added to fluticasone. The 
condition of the patient improved substantially, and she was discharged. 
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Fig. 1. Chest X-ray and HRCT on admission (a). CXR showed diffuse granular shadows in 
bilateral lung fields. (b). Chest HRCT scan showed diffuse centrilobular nodules in both 
lung fields in association with thickening of the bronchi and bronchioles. 
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Fig. 2. Photomicrographs of TBB and TBLB specimen. (a). Significant infiltration of 
eosinophil is observed in the bronchial mucosal and submucosal membrane region  
(HE staining x100). (b). Goblet cell metaplasia is observed in the bronchiolar epithelium, and 
eosinophil/monocyte infiltration is observed in the subepithelial region (HE staining x200). 
(c). Epithelial detachment, basal membrane thickening, and eosinophil/mononuclear 
lymphocyte infiltration are observed in the membranous bronchiole  
(HE staining x200). 
4. Discussion 
Recently, several cases of eosinophilic bronchiolitis have been reported in Japan (Table 1). 
Common characteristics include bronchiolitis with eosinophilic infiltration (on imaging 
studies and histopathological examination), obstructive ventilatory impairment, airway 
hyperreactivity, and blood and BAL-fluid eosinophilia. Clinically, eosinophilic bronchiolitis 
must be differentiated from various other diseases associated with eosinophilic infiltration 
and from various types of bronchiolitis and bronchial asthma. Although the radiographic 
findings in our patient, who had a history of sinusitis, resembled those in diffuse 
panbronchiolitis (DPB), the histological findings were not consistent with DPB, which is 
characterized by accumulations of mononuclear cells (predominantly lymphocytes, plasma 
cells and foamy histiocytes) in the walls of respiratory bronchioles.  
The histological evaluation of TBLB specimens such as those obtained in our patient has 
inherent limitations as compared with lung biopsy specimens obtained surgically, in which 
the walls of bronchioles can undergo complete microscopical examination. Inhaled steroids 
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alone are not adequately effective in many patients; a moderate dose of oral steroids is 
usually very effective. However, decreasing the dose of steroids often triggers a recurrence, 
suggesting that long-term therapy with a maintenance dose of steroids is necessary. 
Our patient did not respond to guideline-based treatment for asthma at other clinics. 
However, the patient showed airway hyperreactivity, and the eNO level had increased to 
184.4 ppb at admission (Rodway et al., 2009). The clinical features and the results of 
laboratory and histopathological examinations led to a diagnosis of bronchial asthma 
associated with eosinophilic bronchiolitis. In 5 previously reported cases (Table 1), not 
including the present one, biopsy specimens of the lung were obtained under video-assisted 
thoracoscopic guidance. This is a very useful technique for obtaining a sufficient quantity of 
peripheral lung lobules for histological examination, but is more invasive than 
bronchoscopic lung biopsy. Fortunately, we could make a diagnosis by bronchoscopic TBLB 
and TBB. The patient responded to treatment with 40 mg of oral prednisolone and is 
currently also receiving fluticasone and HFA-beclomethasone (considering delivery to the 
peripheral airways). The dosage of oral prednisolone was decreased to 2.5 mg on alternative 
days.  
 
 
Case 
Age 
/Sex 
Present 
signs and 
symptoms 
Bronchial 
asthma 
Time 
to EB 
Onset 
Therapy Outcome 
Year 
Author 
1 
46 
/M 
Dyspnea, 
wheeze, 
cough 
-
(Airway 
hyper- 
reactivity +) 
3 
years 
Oral PSL 40 mg 
Recurrence
Dose of 
PSL 
decreased 
2001 
Takayanagi 
et al 
2 
23 
/M 
Dyspnea, 
wheeze, 
cough 
-
(Airway 
hyper- 
reactivity +)
3 
months 
Oral PSL 30 mg 
ICS 
Recurrence
Dose of 
PSL 
decreased
2003 
Nakagome 
 et al 
3 
62 
/F 
Dyspnea, 
cough 
+ 
4 
years 
mPSL 80 mg 
d.i.v. 
Oral PSL, ICS 
Recurrence
Dose of 
PSL 
decreased 
2004 
Nagata 
et al 
4 
50 
/F 
Chest 
shadow 
+ 
5 
years 
Hydrocortisone
300 mg d.i.v. 
Oral PSL 30 mg 
No 
recurrence 
2006 
Tsuburai 
et al 
5 
42 
/M 
Dyspnea, 
cough 
+ 
6 
months 
 
Oral PSL 30 mg 
Recurrence
Dose of 
PSL 
decreased 
2006 
Morimoto 
et al 
6* 
56 
/F 
Dyspnea, 
wheeze, 
cough 
+ 
8 
years 
Oral PSL 40mg 
ICS 
No 
recurrence 
Present 
case 
EB, eosinophilic bronchiolitis; PSL, prednisolone; mPSL, methylprednisolone; ICS, inhaled 
corticosteroids; d.i.v., drip intravenous infusion. 
Table 1. Clinical characteristics of patients with EB reported in previous studies, including 
present case* 
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Since the late 1990’s, eosinophilic airway inflammation, a cardinal sign of bronchial 
asthma, has been confirmed in the peripheral as well as the central airways (Hamid et al., 
1997; Travis et al., 2002). The bronchiolar region may also be involved in asthma 
(International Consensus Report on Diagnosis and Treatment of Asthma, 1992). However, 
cases showing centrilobular granular shadows on chest CT scans have not been studied in 
detail. Eosinophilic bronchiolitis was first reported in 2001, and several other similar cases 
were subsequently reported in Japan (Takayanagi et al., 2001; Nakagome et al., 2003; 
Nagata et al., 2004; Tsuburai et al., 2006; Morimoto et al., 2006). The present case was 
introduced because we believe that it satisfies the proposed diagnostic criteria. Studies of 
additional cases of eosinophilic bronchiolitis are necessary to establish the concept for this 
disease and to further elucidate its pathophysiology and thereby determine whether 
eosinophilic bronchiolitis should be classified as a subtype of bronchial asthma or as a 
distinct entity. 
5. Conclusion 
We described a case of bronchial asthma that showed diffuse centrilobular granular 
shadows and airway thickening on CT of the chest and was diagnosed as eosinophilic 
bronchitis/bronchiolitis on histopathological examination. Recently, several cases of 
eosinophilic bronchiolitis associated with bronchial asthma have been reported. But further 
studies should be needed to elucidate the pathogenesis and pathophysiology of eosinophilic 
bronchitis/bronchiolitis. 
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